{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-077127","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2026-07-10T20:02:00+00:00","discovered_at":"2026-07-10T20:03:00.332287+00:00","generated_at":"2026-07-10T20:03:07.847139+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InMed amends merger with Mentari; files S-4; clarifies name change, redomestication, tax treatment","bullets":["Amendment clarifies sequencing: InMed will change name to Mentari Therapeutics and redomesticate to Nevada before closing.","Amendment introduces Company PIPE Amendment concept to facilitate additional pre-closing financing and clarifies impact on exchange ratio.","Tax treatment clarified: First and Second Mergers intended to qualify as a reorganization under Section 368(a) of the IRC.","Merger expected to close in Q4 2026, subject to shareholder approvals, S-4 effectiveness, and other conditions.","InMed filed Form S-4 on July 2, 2026, containing preliminary proxy statement/prospectus and management information circular."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-077127","json":"https://secwatch.observer/filing/0001213900-26-077127.json","markdown":"https://secwatch.observer/filing/0001213900-26-077127.md","text":"https://secwatch.observer/filing/0001213900-26-077127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390026077127/0001213900-26-077127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390026077127/ea0297284-8k425_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T20:03:07.847139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}